Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.

PLoS One

Published: December 2021

[This corrects the article DOI: 10.1371/journal.pone.0253021.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719726	PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0262326	PLOS

Publication Analysis

correction a real-world

real-world evaluation

evaluation radium-223

radium-223 combination

combination abiraterone

abiraterone enzalutamide

enzalutamide treatment

treatment metastatic

metastatic castration-resistant

castration-resistant prostate

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!